BIRC5 and neoplasm: Both in vitro and in vivo studies demonstrated that this non-viral vector efficiently delivered Survivin siRNA to HCC cells, which resulted in obvious tumor cell apoptosis and the significant inhibition of Bel-7402 tumor growth.